DNTH vs PH · rev $6.2M vs P/E 28, rev $19.85B
Dianthus Therapeutics Inc. (DNTH) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
DNTH currently screens at market cap $4.40B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the DNTH and PH stock pages for the full models.
Not investment advice.